MedMeetings – Translate Knowledge Into the Practice

EASD 2025

Combined Point-of-Care Devices, DPN-Check and SUDOSCAN, Diagnose Early DPN and Predict Diabetic Foot Ulceration and All-Cause Mortality: The Sheffield Prospective Study

The groundbreaking study was presented on Monday, September 15th, 2025

Mukul Ayachit December 24, 2025

EASD 2025

Effectiveness of SGLT-2i’s vs GLP-1RAs on Diabetic Foot Disease: An Emulated Target Trial

The comprehensive study was presented on Monday, September 15th, 2025

Mukul Ayachit December 23, 2025

EASD 2025

The GLP1-Receptor Agonist Semaglutide As an Adjunct to a Lifestyle Intervention in the Treatment of Type 2 Diabetes: Effects on Glucose Metabolism

The trial study was presented on Monday, September 15th, 2025

Mukul Ayachit December 22, 2025

EASD 2025

Sustained Impact of Dapagliflozin on Epicardial Fat Thickness in Type 2 Diabetes: Insights from the DAPAHEART 4-Year Experience

The groundbreaking study was presented on Monday, September 15th, 2025

Mukul Ayachit December 18, 2025

EASD 2025

Mortality, Kidney, and Safety Outcomes with SGLT-2 Inhibitors vs DPP4 Inhibitors in Patients with Type 2 Diabetes Treated with Systemic Glucocorticoids

The research study was presented on Monday, September 15th, 2025

Mukul Ayachit December 17, 2025

EASD 2025

Precision Medicine in Type 2 Diabetes: Targeting GLP1 Receptor Agonist and SGLT-2 Inhibitor Combination Treatment for Kidney Protection

The comprehensive study was presented on Monday, September 15th, 2025

Mukul Ayachit December 15, 2025

Latest Articles

Societies

Speciality